Consultations

Have your say on proposed amendments to the Poisons Standard, to be considered at advisory committees in November 2023.

The TGA is conducting a public consultation and seeking feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.

We are seeking feedback on the proposed new ‘Guidelines for the Quality of Listed Probiotic Medicines’.

The TGA is seeking feedback on how we select medical device applications for audit and how we conduct these audits. Closing date 4 September 2023.

The TGA periodically reviews requirements for medical devices to ensure they continue to be appropriate. Closing 28 July 2023.

The TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023

Proposed amendments to the Poisons Standard. Closing date: 17 May 2023

The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023

The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023

The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023

The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023

The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2023-24 financial year. Closing date: 20 March 2023

Consultation seeking feedback on the repurposing of medicines to inform the development of options for Government consideration closed 1 April 2022

The TGA is seeking feedback on improvements to the therapeutic goods recalls process. Closing 13 March 2023.

This consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).

This consultation is for interim decisions made in relation to the other substances that were discussed at the November 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

Proposed amendments to the Poisons Standard. Closing date: 3 February 2023

Closed: 15 September 2022. Consultation results are now available on the TGA Consultation Hub

The TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products (NVPs) in Australia.

The TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

This consultation is for interim decisions made in relation to Psilocybine and MDMA proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS).

The TGA is seeking feedback on the draft guidance ‘Boundary and combination products - medicines, medical devices, and biologicals’.

The TGA is seeking feedback on whether certain international scientific guidelines should be adopted.

The TGA is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).